Cultures, products and methods using stem cells
    124.
    发明申请
    Cultures, products and methods using stem cells 有权
    使用干细胞的培养,产品和方法

    公开(公告)号:US20040136967A1

    公开(公告)日:2004-07-15

    申请号:US10647361

    申请日:2003-08-25

    Abstract: Stem cells from human sources can have a variety of useful applications in disease treatment and biotechnology. More particularly the umbilical cord matrix cell cultures of the invention have a variety of totipotent, pluripotent, or multipotent cells for a variety of end uses from a non-controversial, universally available, species-specific source. The technology can have application to any amniotic animal, including agricultural and laboratory animals and humans. The invention relates to isolating the stem cells, culturing the stem cells, maintaining the stem cells, transforming the stem cells into useful cell types using genetic or other transformation technologies, stem cell and tissue banking and using untransformed or transformed cells in disease treatment.

    Abstract translation: 来自人源的干细胞可以在疾病治疗和生物技术中具有多种有用的应用。 更具体地,本发明的脐带基质细胞培养物具有各种全能,多能或多能细胞,用于从无争议的,普遍可用的物种特异性来源的各种最终用途。 该技术可以应用于任何羊膜动物,包括农业和实验动物和人类。 本发明涉及分离干细胞,培养干细胞,保持干细胞,使用遗传或其它转化技术将干细胞转化为有用的细胞类型,干细胞和组织库,以及在疾病治疗中使用未转化或转化的细胞。

    Cultures, products and methods using stem cells
    125.
    发明申请
    Cultures, products and methods using stem cells 审中-公开
    使用干细胞的培养,产品和方法

    公开(公告)号:US20030161818A1

    公开(公告)日:2003-08-28

    申请号:US10083779

    申请日:2002-02-25

    CPC classification number: C12N5/0607 A61K35/12 A61K48/00

    Abstract: Stem cells from human sources can have a variety of useful applications in disease treatment and biotechnology. More particularly the umbilical cord matrix stem (UCMS) cell cultures of the invention have a variety of totipotent, pluriotent, or multipotent cells for a variety of end uses from a non-controversial, universally available, species-specific source. The technology can have application to any placental animal, including agricultural and laboratory animals and humans. The invention relates to isolating, culturing the stem cells, maintaining the stem cells, transforming the stem cells into useful cell types using genetic or other transformation technologies, stem cell and tissue banking and using untransformed or transformed cells in disease treatment.

    Abstract translation: 来自人源的干细胞可以在疾病治疗和生物技术中具有多种有用的应用。 更具体地,本发明的脐带基质干细胞(UCMS)细胞培养物具有多种全能,多产或多能细胞,用于从无争议的,普遍可用的物种特异性来源的多种最终用途。 该技术可以应用于任何胎盘动物,包括农业和实验动物和人类。 本发明涉及分离,培养干细胞,保持干细胞,使用遗传或其他转化技术,干细胞和组织库,以及在疾病治疗中使用未转化或转化的细胞将干细胞转化为有用的细胞类型。

    SYNTHESIS OF SUBSTANTIALLY MONODISPERSED COLLOIDS
    126.
    发明申请
    SYNTHESIS OF SUBSTANTIALLY MONODISPERSED COLLOIDS 失效
    合成单体胶原蛋白

    公开(公告)号:US20030072874A1

    公开(公告)日:2003-04-17

    申请号:US09977838

    申请日:2001-10-15

    CPC classification number: B82Y30/00 B01J13/0043 Y10S977/773 Y10S977/896

    Abstract: A method of forming ligated nanoparticles of the formula Y(Z)x, where Y is a nanoparticle selected from the group consisting of elemental metals having atomic numbers ranging from 21-34, 39-52, 57-83 and 89-102, all inclusive, the halides, oxides and sulfides of such metals, and the alkali metal and alkaline earth metal halides, and Z represents ligand moieties such as the alkyl thiols. In the method, a first colloidal dispersion is formed made up of nanoparticles solvated in a molar excess of a first solvent (preferably a ketone such as acetone), a second solvent different than the first solvent (preferably an organic aryl solvent such as toluene) and a quantity of ligand moieties; the first solvent is then removed under vacuum and the ligand moieties ligate to the nanoparticles to give a second colloidal dispersion of the ligated nanoparticles solvated in the second solvent. If substantially monodispersed nanoparticles are desired, the second dispersion is subjected to a digestive ripening process. Upon drying, the ligated nanoparticles may form a three-dimensional superlattice structure.

    Abstract translation: 形成式Y(Z)x的连接纳米颗粒的方法,其中Y是选自原子序数范围为21-34,39-52,57-83和89-102的元素的纳米颗粒,全部 这些金属的卤化物,氧化物和硫化物以及碱金属和碱土金属卤化物,Z表示配体部分,例如烷基硫醇。 在该方法中,由摩尔过量的第一溶剂(优选酮如丙酮),不同于第一溶剂的第二溶剂(优选有机芳基溶剂如甲苯)溶剂化的纳米颗粒形成第一胶态分散体, 和一定数量的配体部分; 然后在真空下除去第一溶剂,并将配体部分连接到纳米颗粒上,得到在第二溶剂中溶剂化的连接的纳米颗粒的第二胶体分散体。 如果需要基本上单分散的纳米颗粒,则将第二分散体进行消化成熟过程。 干燥后,连接的纳米颗粒可形成三维超晶格结构。

Patent Agency Ranking